The Genetics Podcast – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

The Genetics Podcast

The Genetics Podcast

Sano Genetics

Science
Science
Science

Frequency: 1 episode/13d. Total Eps: 198

bCast
Exploring all things genetics. Dr Patrick Short, University of Cambridge alumnus and CEO of Sano Genetics, analyses the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research. To find out more about Sano Genetics and its mission to accelerate the future of precision medicine visit: www.sanogenetics.com
Site
RSS
Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

  • 🇬🇧 Great Britain - naturalSciences

    02/08/2025
    #28

  • 🇺🇸 USA - naturalSciences

    02/08/2025
    #51

  • 🇫🇷 France - naturalSciences

    02/08/2025
    #93

  • 🇬🇧 Great Britain - naturalSciences

    01/08/2025
    #92

  • 🇺🇸 USA - naturalSciences

    01/08/2025
    #75

  • 🇫🇷 France - naturalSciences

    01/08/2025
    #65

  • 🇬🇧 Great Britain - naturalSciences

    31/07/2025
    #83

  • 🇺🇸 USA - naturalSciences

    31/07/2025
    #81

  • 🇫🇷 France - naturalSciences

    31/07/2025
    #78

  • 🇬🇧 Great Britain - naturalSciences

    30/07/2025
    #69

Spotify

    No recent rankings available

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all
RSS feed quality
To improve

Score global : 48%

Publication history

Monthly episode publishing history over the past years.

Episodes published by month in

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

EP 149: Sequencing 33 million samples to support the UK’s COVID-19 response with Tony Cox, CEO of UK Biocentre

Season 1 · Episode 149

jeudi 29 août 2024 • Duration 34:16

In this episode, we’re joined by Tony Cox, CEO of UK Biocentre. After spending more than 20 years at The Wellcome Sanger Institute, where he worked on the Human Genome Project, Tony moved to UK Biocentre in January 2020 – just before the world was turned upside down by the COVID-19 pandemic. The organization pivoted to play a key role in the UK’s response effort, and under Tony’s leadership the center sequenced 33 million DNA samples in just two years. Patrick and Tony discussed receiving a phone call from the UK government, scaling from sequencing 1,000 to 100,000 samples per day, and how to manage producing five tonnes of cardboard waste on a daily basis.

EP 148: Advancing veteran health through the Million Veteran Program with Dr. Mike Gaziano, professor of medicine at Harvard Medical School

Season 1 · Episode 148

jeudi 22 août 2024 • Duration 35:13

This week, we welcome Dr. Mike Gaziano, professor of medicine at Harvard Medical School and the Director of the Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC). Mike is also one of two Principal Investigators of the Million Veteran Program - a national research project in the US looking at how genes, lifestyle, military experiences, and exposures affect health and wellness in veterans. This is a huge undertaking, as Mike describes this project as “the largest health system-based mega-biobank in the world". Join Patrick and Dr. Mike for a discussion on the Million Veteran Program’s research, its integration of extensive data from veterans, and its role in shaping the future of personalized medicine for the veteran community.

EP 139: Rare disease breakthroughs using tRNA with Michelle Werner, CEO of Alltrna and CEO-Partner of Flagship Pioneering

Season 1 · Episode 139

jeudi 20 juin 2024 • Duration 44:42

This week, we welcome Michelle Werner, CEO of Alltrna and CEO/Partner at Flagship Pioneering. Michelle and her team are working at the cutting-edge of tRNA therapies, which they hope will present a scalable treatment method for people in the rare and ultra-rare disease communities. Join Patrick and Michelle for an exciting conversation about this breakthrough technology, from the transferable potential of this new modality across stop codon diseases, to Michelle’s personal passion for delivering workable solutions to the rare disease community.

EP 49: Genomics in education and the social sciences with Dr Daphne Martschenko

0

jeudi 29 octobre 2020 • Duration 45:29:46

Patrick interviews Dr Daphne Martschenko, a postdoctoral research fellow at Stanford University. Daphne’s work has focused on genomics and the American education system. She has published extensively in scholarly journals and mainstream outlets on the topic of education inequity, particularly among young people of color. Patrick and Daphne discuss the history of IQ testing, how genome-wide association analysis and polygenic risk scores are being applied to education, and the ethical issues surrounding gene editing technologies.

EP 48: Tipping the Balance on Ulcerative Colitis with Seb Tucknott

0

mercredi 14 octobre 2020 • Duration 51:02:46

Seb Tucknott is an author and patient advocate who was diagnosed with Ulcerative Colitis in 2008. In 2015 he founded IBD relief, an online community of others with the condition that also provides resources. Seb joins the podcast to discuss how to view the healthcare system from an outsider's perspective, making lifestyle changes, and his 2019 book 'Tipping the Balance'.

EP 47: HDR-UK CEO Caroline Cake: Making the UK a world leader in health data science

0

mercredi 30 septembre 2020 • Duration 40:30:46

Chief Executive Officer of Health Data Research UK Caroline Cake joins Patrick to talk about accelerating medical research through health data science. The two discuss the potential for research and innovation as well as the complexities of issues like patient privacy. Caroline gives Patrick some insight into the history and goals of HDR UK, one of the world’s top institutions for health data science.

EP 46: Rebel Cell: Kat Arney's new book on Cancer, Evolution, and the Science of Life

0

mercredi 16 septembre 2020 • Duration 38:04:46

Kat Arney returns to the podcast to discuss her new book ‘Rebel Cell’, which takes an evolutionary look at cancer. Kat talks about the book beginning as an idea while working on her PhD at Cancer Research UK to spending the last few years researching, conducting interviews and undertaking the book writing process. Patrick and Kat also discuss the narrative of a ‘war on cancer’ and the messaging of ‘beating cancer’ rather than managing it. You can find more information about 'Rebel Cell' and buy it here: https://www.rebelcellbook.com/

EP 45 Steff Di Pardo on Ankylosing Spondylitis and Instagram as a support network for health communities

0

mercredi 2 septembre 2020 • Duration 23:22:46

This week we talk to Steff Di Pardo, a patient advocate and writer who has Ankylosing Spondylitis - which is a chronic autoimmune disease. She talks about the long road to diagnosis, how she started opening up about her condition to friends and family on Facebook, and her decision to bring her refreshing honesty to a wider audience with her blog, Totally Chronic. Steff Di Pardo opens up about her experiences with how her chronic condition has impacted her mental health, being a part of online support networks (on platforms like Instagram) and her new book ‘Just Breathe’ which features short essays on living with a chronic condition.

EP 44 Bringing preventive health to 8 billion people: Peter Würtz from Nightingale Health on their pioneering blood testing platform

0

mercredi 19 août 2020 • Duration 39:28:46

We talk to Peter about Nightingale Health's work with the UK Biobank, including recent research that shows their blood test could be used predict severe COVID19 well before onset of symptoms. The company's vision includes not just population-scale research like the UKBiobank, but creating a system that is focused on prevention and early detection rather than treatment.

EP 43 Diversity in clinical research and COVID19's impact on people with immune conditions with Dr Sonya Abraham.

0

mercredi 5 août 2020 • Duration 43:23:46

Sonya Abraham is a clinical senior lecturer in rheumatology and a research physician at Imperial College London. We talk to her about BAME representation in clinical research and about her rheumatology research, including the role of the microbiome, and what COVID19 researchers can learn from existing rheumatology research. We talk about why diversity is important in clinical trials, and the COVID19 pandemic's impact in the BAME community. We also discuss with Sonya how people with immune conditions, like Ankylosing Spondylitis, Lupus, Rheumatoid Arthritis, and others are at greater risk from COVID19, and uncertainties around the impact of common drugs on COVID19 severity. Finally, we discuss why drugs that were originally used in rheumatology are now providing effective for COVID19 treatment.

Related Shows Based on Content Similarities

Discover shows related to The Genetics Podcast, based on actual content similarities. Explore podcasts with similar topics, themes, and formats, backed by real data.
Curiosity Weekly
DNA Today: A Genetics Podcast
Genetics Unzipped
The Standard
Finding Genius Podcast
This Week in Evolution
Proteomics in Proximity
Small Spark Theory: a marginal gains approach to new business and marketing
Dairy Digressions
The Genetics Podcast
© My Podcast Data
About usPrivacy Policy